These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2650310)

  • 21. Conversion from cyclosporine to azathioprine in heart transplant recipients.
    Stevens L; Halbrook H; Berron K; Spears C; Hormuth D
    J Heart Transplant; 1988; 7(2):119-22. PubMed ID: 3284982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart transplantation in Paris, at "La Pitie" Hospital.
    Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P
    J Heart Transplant; 1985; 4(5):476-80. PubMed ID: 3916522
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute renal failure after heart transplantation and cyclosporine therapy.
    McGiffin DC; Kirklin JK; Naftel DC
    J Heart Transplant; 1985; 4(4):396-9. PubMed ID: 3916513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation].
    Morales J; Mocarquer A; James E; Aris L; Herrera L; Morales I
    Rev Med Chil; 1987 Dec; 115(12):1172-5. PubMed ID: 3332925
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of low-dose cyclosporine A on toxicity and rejection in cardiac transplantation.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    Transplant Proc; 1987 Apr; 19(2):2847-50. PubMed ID: 3551225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjusted triple drug immunosuppression and kidney function following heart transplantation.
    Wahlers T; Cremer J; Fleguth HG; Jurmann M; Herrmann G; Schäfers HJ; Wonigeit K; Haverich A
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2492-3. PubMed ID: 2650314
    [No Abstract]   [Full Text] [Related]  

  • 27. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of different parameters for the monitoring of cyclosporine.
    Humbert H; Vernillet L; Cabiac MD; Barradas J; Billaud E
    Transplant Proc; 1990 Jun; 22(3):1210-5. PubMed ID: 2349682
    [No Abstract]   [Full Text] [Related]  

  • 29. A limited sampling strategy for the measurement of cyclosporine AUC.
    Johnston A; Sketris I; Marsden JT; Galustian CG; Fashola T; Taube D; Pepper J; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1345-6. PubMed ID: 2349694
    [No Abstract]   [Full Text] [Related]  

  • 30. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M; Tazelaar HD; Billingham ME
    J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation.
    Moore CK; Bristow MR; Renlund DG; Rasmussen LG; O'Connell JB
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):25-9. PubMed ID: 2349736
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.
    Tallman MS; Nemunaitis JJ; McGuire TR; Yee GC; Hughes TE; Almgren JD; Appelbaum FR; Higano CS; McGuffin RW; Singer JW
    Transplantation; 1988 Apr; 45(4):810-3. PubMed ID: 3282363
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of toxic side effects of cyclosporine in heart transplantation.
    Schüler S; Warnecke H; Hetzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Clin Transpl; 1989; ():324. PubMed ID: 2487599
    [No Abstract]   [Full Text] [Related]  

  • 38. [Echocardiographic diagnosis of acute graft rejection in heart transplant patients under cyclosporin therapy].
    Angermann CE; Spes CH; Hart RJ; Kemkes BM; Gokel MJ; Thiesen K
    Z Kardiol; 1989 Apr; 78(4):243-52. PubMed ID: 2660449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cardiac rejection in heart and heart-lung transplantation.
    Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
    J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.